EUDA Stock — EUDA Health Holdings Limited

EUDA Health Holdings Limited (EUDA)

Updated October 16, 2026.

EUDA is a Stock. Total return is -92.0% over the past 4.8 years, 168.1 points behind SPY at 76.1%.

EUDA Health Holdings Limited provides non-invasive healthcare services across Singapore, Malaysia, and China, including bioenergy cabin therapy, stem cell therapy through partner treatment centers, wellness products and services, and property management. The company does not currently have an established regular distribution schedule. It may appeal to investors seeking equity exposure to the alternative healthcare and wellness sector in Asia.

EUDA performance versus SPY

Price and return data through 2026-10-16.

Total return is -92.0% over the past 4.8 years, 168.1 points behind SPY at 76.1%. Over the past year its total return — price change plus distributions reinvested — is -77.5%. Its deepest 1-year drawdown was 92.3%.

EUDA key facts

Asset type

Stock

Asset class

Equity

Inception date

12/14/2021

Distribution frequency

None

Last close

$15.40 (as of 2026-10-16)

Market cap

$46,112,605

Average volume

59261.0

Beta

0.586

Payout ratio

0.0%

Forward P/E

7.8064

EPS

$-1.16

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

EUDA risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 92.3%.

Who may consider EUDA — and who may not

It is a weaker fit for investors who need monthly cash flow (EUDA does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on EUDA

• All tickers starting with E

Tagged: Real Estate.

Frequently asked questions